Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Clinical trial NCT00827099 · TERMINATED

Trial details

NCT number: NCT00827099
Sponsor: Northside Hospital, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes

Start date: 2006-06-01
Primary completion: 2009-11-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.